-
FDA expediates approval process for Voyager’s Parkinson’s drug by granting RMAT designation
- June 25, 2018
- Posted by: PharmaScroll
- Category:
No Comments -
Bacteriophages might be a potential cause of Parkinson’s disease, research finds
- June 12, 2018
- Posted by: PharmaScroll
- Category:
-
Oxford BioMedica & Axovant Sciences sign a $842.5 Mn deal for Parkinson’s Drug
- June 7, 2018
- Posted by: PharmaScroll
- Category:
-
Immunosuppressants might lower Parkinson’s risk
- June 1, 2018
- Posted by: PharmaScroll
- Category:
-
Parkinson’s drug ALK4290 by Alkahest receives Grant for Preclinical Evaluation
- May 31, 2018
- Posted by: PharmaScroll
- Category:
-
EMA Validates MAA Submission for Acorda’s INBRIJA for Parkinson’s
- May 31, 2018
- Posted by: PharmaScroll
- Category:
-
Non Motor symptoms for Parkinson’s more common in women as compared to men, study states
- May 27, 2018
- Posted by: PharmaScroll
- Category:
-
Verge Genomics to generate Single Cell Data from Parkinson’s patients
- May 22, 2018
- Posted by: PharmaScroll
- Category:
-
Positive results for AFFITOPE® PD01A in Parkinson’s Disease Patients
- May 20, 2018
- Posted by: PharmaScroll
- Category:
-
Pre-market approval of INSIGHTEC’s device, for Parkinson’s disease, submitted to Japanese PMDA
- May 20, 2018
- Posted by: PharmaScroll
- Category: